Risk factors for predicting severe neutropenia induced by amrubicin in patients with advanced lung cancer.
Watanabe H, Ikesue H, Oshiro M, Nagata K, Mishima K, Takada A, Suetsugu K, Sueyasu M, Egashira N, Harada T, Takayama K, Nakanishi Y, Oishi R.
Watanabe H, et al. Among authors: egashira n.
Chemotherapy. 2012;58(6):419-25. doi: 10.1159/000345617. Epub 2013 Jan 4.
Chemotherapy. 2012.
PMID: 23295219
Free article.